Description
Tesamorelin 15 mg is a catalogue format for a growth hormone-releasing hormone analogue investigated in endocrine signalling research.
Tesamorelin 15 mg: compound identity
A laboratory catalogue entry is not interchangeable with a licensed medicinal formulation. Verify the exact identity and formulation before comparing a material with a publication. No clinical effect or suitability for personal use is claimed.
Documentation and product format
The stated 15 mg describes the catalogue quantity, not a dosing instruction. Confirm the exact formulation, batch identifier, documented content and analytical methods before selecting a material. No independent purity, sterility or testing claim is made for this listing.
Our peptide quality and analytical testing guide explains why identity and chromatographic purity address different questions. Follow verified product-specific handling information and your laboratory’s approved procedures.
Related products and supporting reading
Compare CJC-1295 + Ipamorelin research blend or browse the research peptide catalogue. Find scientific literature on Tesamorelin through PubMed, and use the research library to assess source limitations.
UK delivery and research scope
Read the UK delivery terms: £9.99 delivery, free from a £200 goods subtotal before discounts. This material is presented for in-vitro laboratory research only, not human or veterinary use. Read the research-use disclaimer before selecting materials.
